Search

Search Constraints

You searched for: Author/Creator Matasar, Matthew J.

Search Results

1. Are we ready to predict late effects? A systematic review of clinically useful prediction models. Issue 6 (April 2015)

2. Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide. Issue 2 (February 2015)

3. Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. Issue 20 (10th July 2021)

4. Cancer worry and empathy moderate the effect of a survivorship‐focused intervention on quality of life. Issue 6 (11th March 2020)

5. Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors. (2nd September 2022)

6. Efficacy of a survivorship‐focused consultation versus a time‐controlled rehabilitation consultation in patients with lymphoma: A cluster randomized controlled trial. Issue 23 (18th October 2018)

8. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs. (25th July 2019)

9. Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era. (9th December 2022)

10. Outcomes of primary refractory diffuse large B‐cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era. (16th December 2016)